MedPath

Ore Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Phase 1
Conditions
Mild to Moderate Ulcerative Colitis
Interventions
Drug: Placebo
First Posted Date
2009-12-25
Last Posted Date
2011-06-08
Lead Sponsor
Ore Pharmaceuticals, Inc.
Target Recruit Count
50
Registration Number
NCT01039597
Locations
🇮🇳

B.Y.L. Nair Hospital, Bombay, Maharashtra, India

🇮🇳

St. John's Medical College Hospital, Bangalore, Karnatka, India

🇮🇳

Gut-n-HEPA Care, Indore, Madhya Pradesh, India

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath